Better measures. More power. Fewer patients.
Our technology is improving compliance, patient experience and effect detection in clinical studies

Remote continuous monitoring using clinically validated biometric wearable devices in clinical research
Remote continuous monitoring using clinically validated biometric wearable devices in clinical research

Study Design

We collaborate with our partners to take advantage of new technology to better characterize disease burden or improve the power to detect treatment effects.

Real World Data Integration

Our software enables integration of patient generated data via mobile devices, remote biometrics, and digital health tools in compliance with industry standards and regulations.

Analytics Platform

Our analytics platform has the ability to aggregate, link, monitor and analyze continuous and high volume data sources that are not supported by traditional clinical trial systems or analysis packages.


Koneksa clinical trial monitoring software to capture biometric wearable device data

Capture, monitor and analyze patient generated data and outcomes in clinical studies.


Data Points Measured


Megabytes of Subject Data


Koneksa Health to Present Asthma Study at the 2018 American Thoracic Society (ATS) International Conference

Koneksa Health, an early-stage company focused on the integration of real-world data into clinical research, announced today that it will present results of its validation study of remote FEV1 measurements at the America ... 

Continue reading  ›


ActiGraph Launches CentrePoint Toolkit to Provide Technology Framework for Home-­based Healthcare Solutions

Pensacola, FL – Nov 15, 2016 -­ ActiGraph, a leading provider of clinical-­grade wearable activity and sleep monitoring solutions, has announced the launch of the CentrePoint technology toolkit, which enables clients to  ...

Continue reading 


Takeda and Koneksa Health Announce Strategic Collaboration to Use Digital Health Tools in Clinical Trials

Cambridge, Mass. , and New York, NY, USA,  November 7, 2016 – Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and Koneksa Health, Inc. (“Koneksa”), an early stage company focused on the integration of real ...

Continue reading  ›